Zuckerman Investment Group LLC Has $8.23 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Zuckerman Investment Group LLC reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 68.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 118,860 shares of the company’s stock after selling 254,920 shares during the period. Zuckerman Investment Group LLC owned about 0.10% of Henry Schein worth $8,225,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Olstein Capital Management L.P. lifted its position in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after purchasing an additional 16,000 shares during the last quarter. Private Management Group Inc. raised its holdings in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Equitable Trust Co. acquired a new stake in shares of Henry Schein during the fourth quarter worth $417,000. Savant Capital LLC increased its position in shares of Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock valued at $322,000 after buying an additional 1,420 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock worth $1,113,000 after acquiring an additional 3,650 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $66.16 on Thursday. The stock has a market capitalization of $8.22 billion, a P/E ratio of 27.23, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The business has a 50-day moving average price of $72.55 and a two-hundred day moving average price of $72.32. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the firm earned $0.66 EPS. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on HSIC. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. StockNews.com upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, UBS Group lowered their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.